Home Cart Sign in  
Chemical Structure| 90-45-9 Chemical Structure| 90-45-9

Structure of 9-Aminoacridine
CAS No.: 90-45-9

Chemical Structure| 90-45-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

9-Aminoacridine, a highly fluorescent dye, is commonly used as a antiseptic in clinical and a mutagen or pH indicator in scientific research.

Synonyms: Aminacrine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ingraham, Charles H. IV ; Stalinska, Joanna ; Carson, Sean C. ; Colley, Susan B. ; Rak, Monika ; Lassak, Adam , et al.

Abstract: Glioblastomas are highly aggressive brain tumors for which therapeutic options are very limited. In a quest for new anti-glioblastoma drugs, we focused on specific structural modifications to the benzoyl-phenoxy-acetamide (BPA) structure present in a common lipid-lowering drug, fenofibrate, and in our first prototype glioblastoma drug, PP1. Here, we propose extensive computational analyses to improve the selection of the most effective glioblastoma drug candidates. Initially, over 100 structural BPA variations were analyzed and their physicochemical properties, such as water solubility (- logS), calculated partition coefficient (ClogP), probability for BBB crossing (BBB_SCORE), probability for CNS penetration (CNS-MPO) and calculated cardiotoxicity (hERG), were evaluated. This integrated approach allowed us to select pyridine variants of BPA that show improved BBB penetration, water solubility, and low cardiotoxicity. Herein the top 24 compounds were synthesized and analyzed in cell culture. Six of them demonstrated glioblastoma toxicity with IC50 ranging from 0.59 to 3.24 µM. Importantly, one of the compounds, HR68, accumulated in the brain tumor tissue at 3.7 ± 0.5 µM, which exceeds its glioblastoma IC50 (1.17 µM) by over threefold.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; 2706-56-1 ; ; ; ; ; ; ; ; 20173-24-4 ; ; ; ; ; ; ; ; 42017-89-0 ; 90-45-9

Alternative Products

Product Details of 9-Aminoacridine

CAS No. :90-45-9
Formula : C13H10N2
M.W : 194.23
SMILES Code : NC1=C(C=CC=C2)C2=NC3=CC=CC=C31
Synonyms :
Aminacrine
MDL No. :MFCD00037839
InChI Key :XJGFWWJLMVZSIG-UHFFFAOYSA-N
Pubchem ID :7019

Safety of 9-Aminoacridine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of 9-Aminoacridine

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
PDR K. pneumoniae LH2020 16 μg/mL 18-24 h To evaluate the antimicrobial activity of 9-AA against pan-drug-resistant K. pneumoniae, showing strong antibacterial effects. Microbiol Spectr. 2023 Jun 15;11(3):e0447422
XDR K. pneumoniae KPWANG 16 μg/mL 18-24 h To evaluate the antimicrobial activity of 9-AA against drug-resistant K. pneumoniae, showing strong antibacterial effects. Microbiol Spectr. 2023 Jun 15;11(3):e0447422
K. pneumoniae ATCC 700603 16 μg/mL 18-24 h To evaluate the antimicrobial activity of 9-AA alone or in combination with rifampin against K. pneumoniae, showing strong antibacterial effects. Microbiol Spectr. 2023 Jun 15;11(3):e0447422
CEM lymphocytes 20 μM 48 h Treatment with 9AA resulted in a decrease in cell viability, with approximately 40% cell death observed. J Virol. 2008 Sep;82(17):8537-47
Peripheral blood mononuclear cells (PBMCs) 20 μM 48 h Treatment with 9AA resulted in a decrease in cell viability, with approximately 50% cell death observed. J Virol. 2008 Sep;82(17):8537-47
HTLV-1-transformed MT2 cells 20 μM 48 h Treatment with 9AA resulted in a dramatic decrease in cell viability, with approximately 90% cell death observed. J Virol. 2008 Sep;82(17):8537-47
HTLV-1-transformed Hut102 cells 20 μM 48 h Treatment with 9AA resulted in a dramatic decrease in cell viability, with approximately 95% cell death observed. J Virol. 2008 Sep;82(17):8537-47
HTLV-1-transformed C8166 cells 20 μM 48 h Treatment with 9AA resulted in a dramatic decrease in cell viability, with approximately 90% cell death observed. J Virol. 2008 Sep;82(17):8537-47

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.15mL

1.03mL

0.51mL

25.74mL

5.15mL

2.57mL

51.49mL

10.30mL

5.15mL

References

 

Historical Records

Categories